Immune checkpoint dysfunction in large and medium vessel vasculitis.

Area of Science:

• Immunology
• Vascular Biology
• Pathology

Background:

• Giant cell arteritis (GCA) is a serious inflammatory condition affecting large arteries.
• It involves immune cells like T cells, macrophages, and dendritic cells (DCs) damaging the vessel wall.
• Pathological changes include vessel wall thickening and narrowing.

Purpose of the Study:

• To investigate the role of immune checkpoints in GCA pathogenesis.
• To understand how T cell regulation is disrupted in GCA.
• To explore the implications for potential therapies.

Main Methods:

• Analysis of immune cell infiltrates in GCA lesions.
• Assessment of immune checkpoint molecule expression (e.g., PD-L1, PD-1) on vessel wall cells.
• Evaluation of T cell activation and cytokine production in the context of immune checkpoint function.

Main Results:

• Vessel wall dendritic cells in GCA fail to express programmed cell death ligand-1 (PD-L1).
• This leads to unchecked activation of programmed cell death protein-1 (PD-1)-positive CD4 T cells within the vessel wall.
• These T cells produce inflammatory cytokines and contribute to intimal hyperplasia and neoangiogenesis.

Conclusions:

• A deficiency in PD-1 immune checkpoint signaling contributes to the autoimmune response in GCA.
• This contrasts with cancer, where checkpoint hyperactivity causes immune evasion.
• Understanding this immune dysregulation may inform new therapeutic strategies for GCA and related vasculitides.